e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Novel drugs and biomarkers in respiratory medicine
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Potential effect of the extract of
zataria multiflora
and its consituent carvacrol on lung inflammation of sensitized guinea pigs
M. H. Boskabady, A. Tabatabaee, S. Jalali (Mashhad, Islamic Republic Of Iran)
Source:
Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Session:
Novel drugs and biomarkers in respiratory medicine
Session type:
Thematic Poster Session
Number:
732
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. H. Boskabady, A. Tabatabaee, S. Jalali (Mashhad, Islamic Republic Of Iran). Potential effect of the extract of
zataria multiflora
and its consituent carvacrol on lung inflammation of sensitized guinea pigs. Eur Respir J 2013; 42: Suppl. 57, 732
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Sakuranetin treatment from baccharis retusa reduces acid mucus in a murine model of asthma
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016
CRAC channel inhibition by RP3128 ameliorates airway hyper-reactivity in antigen sensitized mice and guinea pigs
Source: International Congress 2014 – Novel targets and drugs for asthma and COPD
Year: 2014
Effects of rosemary and platanus extracts on asthmatic subjects resistant to traditional treatments
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013
Resveratrol upregalates PTEN and inhibits MUC5AC expression in ovalbumin (OVA)-induced asthma model mice
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016
A novel inhaled PI3Kδ inhibitor, LAS194223 reduces allergen-induced airway inflammation in rat
Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis
Year: 2014
Carvacrol and pomegranate extract in treating methotrexate-induced lung oxidative injury in rats
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
New inhaled JAK inhibitor LAS194046 inhibits allergen-induced airway inflammation in Brown Norway rats
Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis
Year: 2014
Mucus-normalizing activity of a fixed thyme and primula extract combination: Reduction of LPS-induced goblet cell metaplasia and mucin production in vivo
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
Effects of chronic cigarette smoke exposure on lung inflammation in ovalbumin-sensitized mice
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in the mouse
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013
A molecule derived from mycobacterium tuberculosis
Cpn60.1 (compound Y) inhibits lung inflammation induced by LPS in mice
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Ciclesonide and tiotropium synergistically inhibit airway eosinophilia in a guinea pig model of chronic asthma
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013
Effects of acute hypochlorite exposure in OVA-sensitized and challenged mice
Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models
Year: 2015
Polyphenolic compounds and experimentally induced allergic asthma
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Tiotropium effects on airway inflammatory events in the cat as an animal model for acute cigarette smoke-induced lung inflammation
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Rapamycin protects OVA induced asthma in mice through regulating autophagy
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Evaluation of bronchodilator activity of A. precatorius leaves
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
A combination of thyme and primula dry extracts possesses antitussive activity and inhibits leukotriene formation
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013
Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease
Source: International Congress 2015 – Advances in asthma and allergy in animal models
Year: 2015
Standardization of a murine model of asthma due to soybean inhalation
Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept